MedTrace Logo

Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.

NCT04274374 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-07-08

No results posted yet for this study

Summary

Subclinical intestinal inflammation and gut dysbiosis have been reported in patients with spondyloarthritis (SpA). In common practice, rheumatologists are increasingly confronted with patients with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a GFD on the quality of life of patients with axial SpA.

Conditions

  • Ankylosing Spondyloarthritis

Interventions

DIETARY_SUPPLEMENT

Gluten-Free Diet

Dietary supplement without gluten

DIETARY_SUPPLEMENT

Gluten Diet

Dietary supplement with gluten

Sponsors & Collaborators

  • PANZANI

    collaborator UNKNOWN

  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Marion Couderc, MD · CHU de Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-07
Primary Completion
2025-10-31
Completion
2026-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274374 on ClinicalTrials.gov